Natural Alternatives International INC Stock: price and directors' dealings · United States · SEC (Form 4)Follow the Natural Alternatives International INC share price and the full directors' dealings record of the company, a listed equity based in United States. Shares are listed on the US market, under the supervision of SEC (Form 4). Operating in the Healthcare & Pharma sector, Natural Alternatives International INC has recorded 25 public disclosures. Market capitalisation: €14.7m. The latest transaction was reported on 10 March 2026 (Attribution). Among the most active insiders: LEDOUX MARK A. All data is accessible without an account.
€251,676
4 ops.
Sell Volume
Buys €9,634 €251,676 Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 23,970 of 29,063 companies
FCF yld 17%
Earn yld -100%
EV/EBITDA ·
ROE -21%
Gross mgn 7.2%
Net mgn -10%
Debt/EBITDA ·
Pillars 2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ Sigma AI Analysis Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 10 March 2026
All Executives25 Thresholds0 Prospectus0 Other0
Declarations 25 total
◆ Director · Executives · 6 Mar 2026
8,000 shares 0Common Stock SEC:0001437749-26-007515:0
◆ Director · Executives · 6 Mar 2026
8,000 shares 0Common Stock SEC:0001437749-26-007514:0
◆ Director · Executives · 6 Mar 2026
8,000 shares 0Common Stock SEC:0001437749-26-007513:0
● President, COO, & Sec. · Executives · 6 Mar 2026
5,151 shares @ US$2.73 100.0% of flow Common Stock SEC:0001437749-26-007620:0
● Chief Financial Officer · Executives · 6 Mar 2026
4,308 shares @ US$2.73 100.0% of flow Common Stock SEC:0001437749-26-007619:0
● CEO/Chairman · Executives · 6 Mar 2026
3,484 shares @ US$2.73 3.0% of flow Common Stock SEC:0001437749-26-007618:0
▲ CEO/Chairman · Executives · 4 Mar 2026
500 shares @ US$2.77 0.4% of flow Common Stock SEC:0001437749-26-007255:0
Canonical exit: 2 Jun 2026 (T+90) ▲ CEO/Chairman · Executives · 27 Feb 2026
500 shares @ US$2.85 0.4% of flow Common Stock SEC:0001437749-26-006754:0
Canonical exit: 28 May 2026 (T+90) ▲ CEO/Chairman · Executives · 25 Feb 2026
500 shares @ US$2.81 0.4% of flow Common Stock SEC:0001437749-26-006139:0
Canonical exit: 26 May 2026 (T+90) ▲ CEO/Chairman · Executives · 20 Feb 2026
250 shares @ US$2.655 0.2% of flow Common Stock SEC:0001437749-26-005423:0
Canonical exit: 21 May 2026 (T+90) ▲ CEO/Chairman · Executives · 17 Feb 2026
2,500 shares @ US$2.596 2.0% of flow Common Stock SEC:0001437749-26-004935:0
Canonical exit: 18 May 2026 (T+90) ● CEO/Chairman · Executives · 23 Dec 2025
10,000 shares Common Stock SEC:0001437749-26-000287:0
◆ Director · Executives · 4 Mar 2022
7,000 shares 0Common Stock SEC:0001437749-22-008680:0
◆ Chief Financial Officer · Executives · 4 Mar 2021
11,000 shares 0Common Stock SEC:0001437749-22-005616:0
◆ CEO/Chairman · Executives · 4 Mar 2022
15,000 shares Common Stock SEC:0001437749-22-005612:0
◆ Director · Executives · 4 Mar 2022
7,000 shares 0Common Stock SEC:0001437749-22-005615:0
◆ Director · Executives · 4 Mar 2022
7,000 shares 0Common Stock SEC:0001437749-22-005613:0
◆ President, COO, & Sec. · Executives · 4 Mar 2022
13,000 shares 0Common Stock SEC:0001437749-22-005614:0
● CEO/Chairman · Executives · 23 Dec 2021
5,000 shares Common Stock SEC:0001437749-21-029330:0
▼ CEO/Chairman · Executives · 30 Aug 2021
2,500 shares @ US$15.68 12.3% of flow Common Stock SEC:0001437749-21-021338:0
▼ CEO/Chairman · Executives · 2 Aug 2021
5,300 shares @ US$17.36 28.8% of flow Common Stock SEC:0001437749-21-018558:0
▼ CEO/Chairman · Executives · 12 Jul 2021
5,000 shares @ US$17.50 27.4% of flow Common Stock SEC:0001437749-21-016947:0
▼ CEO/Chairman · Executives · 30 Jun 2021
5,000 shares @ US$15.94 24.9% of flow Common Stock SEC:0001437749-21-016385:0
◇ Director · Executives · 18 May 2021
10,000 shares @ US$3.52 100.0% of flow Common Stock SEC:0001437749-21-012849:0
◇ Director · Executives · 18 May 2021
10,000 shares @ US$3.52 100.0% of flow Common Stock SEC:0001437749-21-012848:0
关于 Natural Alternatives International INC Natural Alternatives International, Inc. (NAII) 是一家在美国纳斯达克市场上市的美国公司。该公司由 Mark LeDoux 于1980年创立,总部位于加利福尼亚州卡尔斯巴德,长期以来一直以双边业务模式运营,在加利福尼亚州和瑞士拥有生产能力。NAII 最好被理解为一家专业的营养平台公司,而非大众市场消费品牌:它为需要定制营养产品的配方、制造和商业化支持的第三方客户提供服务。
公司的核心业务是维生素、矿物质、草本产品和其他膳食补充剂的自有品牌和合同制造。其服务范围超越了代工制造,包括定制配方、临床研究支持、法规遵从、国际产品注册、标签法规支持、包装设计、科学研究和营销协助。这种综合性服务在竞争中非常重要,因为营养行业的许多客户都希望有一个单一的合作伙伴,能够将产品从概念推向货架,同时管理跨司法管辖区的质量、合规性和本地化。
NAII 还围绕其β-丙氨酸成分平台 CarnoSyn® 建立了品牌和知识产权影响力。该成分一直是公司运动营养定位的核心,并随着时间的推移扩展到邻近的健康和抗衰老应用。历史上,公司一直投资于围绕β-丙氨酸递送形式的产品和技术开发,包括速释和缓释版本。对于投资者而言,这很重要,因为专有成分可以支持差异化、客户粘性以及许可或品牌投入经济效益,即使整体合同制造利润率仍面临压力。
从竞争角度来看,NAII 在分散的营养补充剂制造市场中占据一席之地。其优势在于科学主导的配方、法规专业知识和悠久的运营历史;其挑战是该行业的典型问题,包括客户集中度、价格压力、原材料波动以及在所有生产设施中保持质量和合规性的需求。公司在美国和瑞士的地理存在为其服务国内和国际客户提供了平台,这对于寻求全球市场准入的客户尤其重要。
对于搜索引擎优化和投资者背景,值得注意的是,NAII 被市场视为一家小型公司,这意味着其股价对收益发布、合同赢输以及通过 SEC Form 4 文件披露的内部人活动可能具有更高的敏感性。2026年2月,公司公布了第二财季业绩,净销售额为34.8 million美元,净亏损为2.6 million美元。这一最新消息强化了 NAII 作为健康和营养链中一家以执行力为导向的利基供应商的形象,其商业模式与定制补充剂需求、专有成分价值以及在美国和海外的法规信誉紧密相关。